Key Highlights
Through the use of genetic screening, i.e., a companion genetic bio-marker intended to identify patients most likely to respond to therapy, AD04 humanizes the alcohol use disorder treatment, which could lead to an increase in the usage of AD04Without the need for abstinence, AD04’s novel mechanism of action has the potential to curb alcohol cravings by targeting the serotonin system
It is estimated that alcohol use disorder treatment market comprises less than 10% of the entire alcohol use disorder population. Whereas most alcohol use disorder treatments available on the market include social and psychological interventions.
Analysis...
